Recent advances in the prevention or reduction of cytotoxic-induced emesis.
D000932:Antiemetics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects; D001569:Benzodiazepines / Q000008:administration & dosage / Q000627:therapeutic use; D002186:Cannabinoids / Q000627:therapeutic use; D004341:Drug Evaluation; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007263:Infusions, Parenteral; D008787:Metoclopramide / Q000008:administration & dosage / Q000627:therapeutic use; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy*
D000932:Antiemetics; D000970:Antineoplastic Agents; D002186:Cannabinoids; D005938:Glucocorticoids; D001569:Benzodiazepines; D008787:Metoclopramide